Showing results (1-10 of 351) with videos related to
Sort By:
Pageof 36
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 19, 2026
Age (juvenile to aged) and sex effects on in vitro CYP2A6 enzyme activity in African green monkeys using nicotine and coumarinWeilong Gu, Rachel F TyndaleCurrent Drug Metabolism|April 17, 2026
In Vitro Drug-Drug Interactions between Oxycodone and Commonly Co-Consumed Drugs in Rat and Human Liver MicrosomesWeilong Gu, Rachel F TyndalePharmacology Research & Perspectives|July 9, 2025
Extending Investigations of miR-126-5p on the Regulation of CYP2A6, the Major Nicotine-Inactivating EnzymeWeilong Gu, Alec W R Langlois, Haidy Giratallah, et al.The European Journal of Neuroscience|March 30, 2010
Cytochrome P450 2D6 enzyme neuroprotects against 1-methyl-4-phenylpyridinium toxicity in SH-SY5Y neuronal cellsAmandeep Mann, Rachel F TyndaleNeuropharmacology|December 22, 2005
Regional and cellular distribution of CYP2E1 in monkey brain and its induction by chronic nicotineMeenal Joshi, Rachel F TyndaleDrug Metabolism Reviews|July 9, 2004
The unique regulation of brain cytochrome P450 2 (CYP2) family enzymes by drugs and geneticsSharon Miksys, Rachel F TyndaleAddiction Science & Clinical Practice|October 18, 2011
Pharmacogenetics: a tool for identifying genetic factors in drug dependence and response to treatmentMargaret Mroziewicz, Rachel F TyndaleNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 1, 2008
Brain drug-metabolizing cytochrome P450 enzymes are active in vivo, demonstrated by mechanism-based enzyme inhibitionSharon Miksys, Rachel F TyndaleDrug Metabolism and Disposition: the Biological Fate of Chemicals|January 26, 2006
Induction and recovery time course of rat brain CYP2E1 after nicotine treatmentMeenal Joshi, Rachel F TyndalePageof 36